Table 1 Background and disease characteristics among women with JIA at inclusion
From: Breastfeeding in women with juvenile idiopathic arthritis: results from a Norwegian quality register
Background characteristics | N | |
|---|---|---|
Age (years), mean (SD) | 304 | 28.8 (4.3) |
Age > 35 years, n (%) | 23 (7.6) | |
Parity, n (%) | 304 | |
0 | 136 (44.7) | |
1 | 98 (32.2) | |
≥2 | 70 (23.0) | |
Cigarette/Snuff use n (%) | 299 | 30 (10.0) |
BMI (kg/m2), mean (SD) | 293 | 25.0 (4.4) |
Underweight (< 18.5 kg/m2), n (%) | 8 (2.7) | |
Normal weight (18.5–24.9 kg/m2), n (%) | 164 (56.0) | |
Overweight ≥ 25 kg/m2), n (%) | 121 (41.3) | |
Regular physical activity, n (%)a | 201 | 124 (61.7) |
Education level, n (%)b | 298 | |
Low | 10 (3.4) | |
Intermediate | 68 (22.8) | |
High | 220 (73.8) | |
Working full time or part time, n (%) | 298 | 218 (73.2) |
Disease related characteristics | ||
Disease duration in years, mean (SD) | 269 | 21.3 (15.3) |
Erosive disease, n (%) | 251 | 95 (37.8) |
Anti-CCP antibodies present, n (%) | 251 | 34 (13.5) |
RF present, n (%) | 237 | 34 (14.3) |
CRP (mg/L), mean (SD) | 281 | 6.0 (10.2) |
CRP value > 5 mg/L, n (%) | 110 (39.1) | |
DAS-28-CRP-3, mean (SD) | 253 | 2.4 (0.8) |
Remission (DAS-28CRP-3 < 2.6), n (%) | 172 (68.0) | |
Low disease activity (2.6 ≤ DAS-28-CRP-3 ≤ 3.2), n (%) | 46 (18.2) | |
Moderate disease activity (3.2 < DAS-28-CRP-3 ≤ 5.1), n (%) | 34 (13.4) | |
High disease activity (DAS-28-CRP-3 > 5.1), n (%) | 1 (0.4) | |
VAS (mm), mean (SD) | ||
Pain | 228 | 25.2 (23.8) |
Fatigue | 217 | 41.9 (29.5) |
Total | 224 | 29.7 (26.2) |
Medications | ||
csDMARDs, n (%)c | 302 | 68 (22.5)c |
Hydroxychloroquine, n (%) | 17 (5.6) | |
Methotrexate, n (%) | 14 (4.6) | |
Sulfasalazine, n (%) | 38 (12.6) | |
bDMARDs, n (%) | 303 | 94 (31.0) |
TNF inhibitor, n (%) | 90 (29.7) | |
IL-6 inhibitor, n (%) | 4 (1.3) | |
Corticosteroids, n (%) | 303 | 29 (9.6) |